1. Home
  2. IMAB vs HUSA Comparison

IMAB vs HUSA Comparison

Compare IMAB & HUSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMAB
  • HUSA
  • Stock Information
  • Founded
  • IMAB 2014
  • HUSA N/A
  • Country
  • IMAB United States
  • HUSA United States
  • Employees
  • IMAB N/A
  • HUSA N/A
  • Industry
  • IMAB Biotechnology: Pharmaceutical Preparations
  • HUSA Oil & Gas Production
  • Sector
  • IMAB Health Care
  • HUSA Energy
  • Exchange
  • IMAB Nasdaq
  • HUSA Nasdaq
  • Market Cap
  • IMAB 384.6M
  • HUSA 339.8M
  • IPO Year
  • IMAB 2020
  • HUSA N/A
  • Fundamental
  • Price
  • IMAB $4.38
  • HUSA $7.37
  • Analyst Decision
  • IMAB Strong Buy
  • HUSA
  • Analyst Count
  • IMAB 4
  • HUSA 0
  • Target Price
  • IMAB $6.75
  • HUSA N/A
  • AVG Volume (30 Days)
  • IMAB 2.1M
  • HUSA 131.1K
  • Earning Date
  • IMAB 11-02-2025
  • HUSA 08-15-2025
  • Dividend Yield
  • IMAB N/A
  • HUSA N/A
  • EPS Growth
  • IMAB N/A
  • HUSA N/A
  • EPS
  • IMAB N/A
  • HUSA N/A
  • Revenue
  • IMAB N/A
  • HUSA N/A
  • Revenue This Year
  • IMAB N/A
  • HUSA N/A
  • Revenue Next Year
  • IMAB N/A
  • HUSA N/A
  • P/E Ratio
  • IMAB N/A
  • HUSA N/A
  • Revenue Growth
  • IMAB N/A
  • HUSA N/A
  • 52 Week Low
  • IMAB $0.60
  • HUSA $3.85
  • 52 Week High
  • IMAB $5.90
  • HUSA $32.00
  • Technical
  • Relative Strength Index (RSI)
  • IMAB 54.65
  • HUSA 33.97
  • Support Level
  • IMAB $4.17
  • HUSA $8.00
  • Resistance Level
  • IMAB $4.69
  • HUSA $8.56
  • Average True Range (ATR)
  • IMAB 0.53
  • HUSA 0.66
  • MACD
  • IMAB -0.12
  • HUSA -0.11
  • Stochastic Oscillator
  • IMAB 25.44
  • HUSA 7.18

About IMAB I-MAB

I-MAB is a clinical-stage biotech company. Along with its subsidiaries, it is principally engaged in discovering and developing transformational biologics in the fields of immuno-oncology and immuno-inflammation diseases in the People's Republic of China and other countries and regions. Its drug pipeline includes Uliledlimab (TJD5) which is an antibody for solid tumors, Ragistomig (TJ-L14B), and Givastomig (TJ-CD4B).

About HUSA Houston American Energy Corporation

Houston American Energy Corp is an independent oil and gas company focused on the development, exploration, exploitation, acquisition, and production of natural gas and crude oil properties. Its properties, and operations, are in the U.S. Permian Basin, the U.S. Gulf Coast region, particularly Louisiana, and the South American country of Colombia. Geographically, the company currently has operations in two geographical areas, the United States, from where it derives maximum revenue, and Colombia.

Share on Social Networks: